November 2018 - First Report Managed Care

Issue 11
November 2018


Russ J Spjut, PharmD, owner of Formulary Intel Consulting

A few months ago, I wrote an article about my initial impressions of the landscape of calcitonin gene-related peptide (CGRP) receptor antagonists for the treatment of migraines just after the launch of the first drug approved in this class, Aimovig (erenumab, Amgen). | Read More
Researchers recently found that patients with type 2 diabetes taking metformin, a common diabetes medication, had a much lower rate of age-related macular degeneration (AMD).  | Read More
The efficacy and safety of EyePoint Pharmaceuticals Yutiq (fluocinolone acetonide intravitreal implant) 0.18 mg 3-year micro-insert for the treatment of chronic noninfectious uveitis affecting the posterior segment of the eye was supported by 24-month follow-up data presented at the Annual Meeting of the American Academy of Ophthalmology. | Read More
Currently, detecting Alzheimer disease (AD) is a challenge. However, a new, noninvasive imaging device—which examines the smallest veins in the back of the eye, including the red blood cells moving through the retina—can be used to detect signs of AD, researchers said. | Read More